Genetic sequencing revealed unique responses to rosuvastatin medication for Nickhil Jakatdar. His body processes the statin more slowly than average, influencing future treatment decisions.
A variant associated with Gilbert syndrome was also identified through his genome. This finding indicated that prolonged intermittent fasting might not be universally beneficial for him.
These nuanced genetic insights provided confidence to tailor his health approach.
This story was reported by The Times of India. Read the full coverage at The Times of India.
